跳至主要内容
临床试验/NCT01220115
NCT01220115已完成不适用

A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease Patients

Novartis42 个研究点 分布在 1 个国家目标入组 498 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Novartis
入组人数
498
试验地点
42
主要终点
Document current treatment patterns, natural history and outcomes in patients with sickle cell disease

研究概览

简要总结

A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and outcomes in sickle cell disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients with HbSS, HbS/beta-thalassemia and HbSC
  • Age > 2 years old.
  • Written informed consent by the patient or legal guardians, and pediatric assent where indicated.

排除标准

  • Patients with Sickle Cell trait (HbAS) are not eligible for the study
  • Patient or legal guardians unable or unwilling to give consent, or pediatric assent where indicated.

结局指标

主要结局

Document current treatment patterns, natural history and outcomes in patients with sickle cell disease

时间窗: up to 5 years

次要结局

  • Measure Sickle cell crisis and hospitalizations(up to 5 years)
  • Data collection(up to 5 years)

研究者

发起方
Novartis
申办方类型
Industry
责任方
Sponsor

研究点 (42)

Loading locations...

相似试验